Nvidia, Pfizer Transform SE Asia Drug Discovery with AI Breakthroughs

Nvidia and Pfizer are using AI to make huge steps forward in drug development in Southeast Asia.

Nvidia revealed a strategic partnership with Pfizer, an American biopharmaceutical company, and a number of Singaporean groups. The goal is to help Southeast Asian healthcare companies grow around the world.

The new Ignition AI Accelerator program aims to speed up the creation of new medicines and help the local pharmaceutical industry grow.

AI tools will be used in the program to shorten the time it takes to create new drugs, look at large datasets, and give faster insights, which could help new healthcare companies.

Key stakeholders, such as government agencies, universities, and business accelerators, will be encouraged to work together and integrate as part of this effort.